Leicester, NY, October 1, 2003 - CPAC, Inc. (Nasdaq: CPAK) today announced the appointment of José J. Coronas to its Board of Directors. Outside directors now occupy four of the six CPAC Board seats.
Mr. Coronas, 61, is a General Partner in Trillium Group, a Rochester-based venture capital firm. Upon his retirement in 1997 as President of Johnson & Johnson Clinical Diagnostics, Inc., Mr. Coronas helped form Trillium Group. Prior to Johnson & Johnson, he had various senior management positions with Eastman Kodak, including Vice President and General Manager of its Clinical Diagnostics Division, where he led the sale of the division to Johnson & Johnson. Mr. Coronas also engineered the formation of Genencor International, Inc., a joint venture of Kodak and Cultor Ltd., and served as its first President and CEO.
According to Thomas N. Hendrickson, CPAC, Inc. President and CEO, "Mr. Coronas brings a wealth of operating management and strategic alliance experience in Imaging markets to CPAC. He will provide solid guidance as we execute the strategic direction for our two business segments during these trying economic times. We are extremely pleased that Mr. Coronas has agreed to join our Board as an outside director."
A native of Cuba, Mr. Coronas earned a BS in Industrial Engineering from the University of Miami. He received an MBA with honors from the University of Rochester Simon School Executive Development Program, where he now serves as a member of the Executive Advisory Committee. Mr. Coronas also is on the Board of Trustees of St. John Fisher College, Monroe Community College Foundation, and Hillside Children's Foundation. Mr. Coronas and his wife Karen live in Pittsford, NY and have two grown children.
About CPAC, Inc.
Established in 1969, CPAC, Inc. (www.cpac.com) manages holdings in two industries. The Fuller Brands segment manufactures commercial, industrial, and household cleaning products, as well as custom brushes and personal care lines. The CPAC Imaging segment develops and markets innovative Imaging chemicals, equipment, and supplies at seven business units worldwide. Products are sold under more than 350 registered trademarks. Stock is traded under the symbol: CPAK.
Except for the historical matters contained herein, statements in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements involve risks and uncertainties, which may affect CPAC's business and prospects, including economic, competitive, governmental, technological, and other factors discussed in CPAC's filings with the Securities and Exchange Commission.
# # #
|
